← Feed

$MDCX

2 theses
bullish 100%neutral 0%bearish 0%
Avg return (3m)
—
Win rate (3m)
— (0 resolved)
1d3d1w1m3m6m1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Sep 14, 4:30 PM ET
$MDCXSEC 13Dbullish
BOKHARI, RAZA · beneficial owner of Medicus Pharma Ltd. · 3h agono track record yet
Long 4,859,349 shares of MDCX
4,859,349 shares · 5.3% of class · 2026-09-04

Schedule 13D: BOKHARI, RAZA disclosed a stake in MDCX

BOKHARI, RAZA disclosed a 5.3% stake of 4,859,349 shares in Medicus Pharma Ltd. (MDCX) in a Schedule 13D filed 2026-09-14.

At post $0.16Now $0.160.0% since postedas of Sep 14, 4:30 PM ET
View filing on SEC.gov →
$MDCXr/pennystocksDDbullish
u/One-Dingo1220 · 102d ago2 prior · awaiting results

$MDCX(Medicus Pharma — $22M non-dilutive financing secured, multiple clinical catalysts ahead on a sub $1 biotech

Medicus Pharma secured $22M non-dilutive debt financing with multiple clinical catalysts ahead: SkinJect Phase 2 data shows promising efficacy in BCC with no serious safety issues, Phase 2b registrational trial underway for Gorlin Syndrome, and pursuit of Orphan Drug Designation and Rare Pediatric Disease voucher could accelerate regulatory pathway. Teverelix advancing in prostate cancer positions company for multi-billion-dollar market opportunity.

At post $0.37Now $0.16-57.4% since postedas of Sep 14, 4:30 PM ET
original post →

End of results.